236 related articles for article (PubMed ID: 32573499)
1. TPL2 enforces RAS-induced inflammatory signaling and is activated by point mutations.
Dodhiawala PB; Khurana N; Zhang D; Cheng Y; Li L; Wei Q; Seehra K; Jiang H; Grierson PM; Wang-Gillam A; Lim KH
J Clin Invest; 2020 Sep; 130(9):4771-4790. PubMed ID: 32573499
[TBL] [Abstract][Full Text] [Related]
2. Cystatin cures visceral leishmaniasis by NF-κB-mediated proinflammatory response through co-ordination of TLR/MyD88 signaling with p105-Tpl2-ERK pathway.
Kar S; Ukil A; Das PK
Eur J Immunol; 2011 Jan; 41(1):116-27. PubMed ID: 21182083
[TBL] [Abstract][Full Text] [Related]
3. Tpl2 kinase signal transduction in inflammation and cancer.
Vougioukalaki M; Kanellis DC; Gkouskou K; Eliopoulos AG
Cancer Lett; 2011 May; 304(2):80-9. PubMed ID: 21377269
[TBL] [Abstract][Full Text] [Related]
4. The kinase TPL2 activates ERK and p38 signaling to promote neutrophilic inflammation.
Senger K; Pham VC; Varfolomeev E; Hackney JA; Corzo CA; Collier J; Lau VWC; Huang Z; Hamidzhadeh K; Caplazi P; Peng I; Setiadi AF; Francis R; Paler-Martinez A; Kwon YC; Ramirez-Carrozzi V; Sun Y; Grigg PW; Roose-Girma M; Jeet S; Barck KH; Pham A; Ota N; Ha C; Stinson J; Guillory J; Tam L; Modrusan Z; Emson C; McKenzie BS; Townsend MJ; Carano RAD; Warming S; Vucic D; DeVoss J; Lee WP; Lill JR; Zarrin AA
Sci Signal; 2017 Apr; 10(475):. PubMed ID: 28420753
[TBL] [Abstract][Full Text] [Related]
5. Tumor progression locus 2 (TPL2) in tumor-promoting Inflammation, Tumorigenesis and Tumor Immunity.
Njunge LW; Estania AP; Guo Y; Liu W; Yang L
Theranostics; 2020; 10(18):8343-8364. PubMed ID: 32724474
[TBL] [Abstract][Full Text] [Related]
6. Tumor progression locus 2 (Tpl2) kinase promotes chemokine receptor expression and macrophage migration during acute inflammation.
Rowley SM; Kuriakose T; Dockery LM; Tran-Nguyen T; Gingerich AD; Wei L; Watford WT
J Biol Chem; 2014 May; 289(22):15788-97. PubMed ID: 24713702
[TBL] [Abstract][Full Text] [Related]
7. Tumor Progression Locus 2 (Tpl2) Activates the Mammalian Target of Rapamycin (mTOR) Pathway, Inhibits Forkhead Box P3 (FoxP3) Expression, and Limits Regulatory T Cell (Treg) Immunosuppressive Functions.
Li X; Acuff NV; Peeks AR; Kirkland R; Wyatt KD; Nagy T; Watford WT
J Biol Chem; 2016 Aug; 291(32):16802-15. PubMed ID: 27261457
[TBL] [Abstract][Full Text] [Related]
8. TPL2 kinase regulates the inflammatory milieu of the myeloma niche.
Hope C; Ollar SJ; Heninger E; Hebron E; Jensen JL; Kim J; Maroulakou I; Miyamoto S; Leith C; Yang DT; Callander N; Hematti P; Chesi M; Bergsagel PL; Asimakopoulos F
Blood; 2014 May; 123(21):3305-15. PubMed ID: 24723682
[TBL] [Abstract][Full Text] [Related]
9. IRAK1-independent pathways required for the interleukin-1-stimulated activation of the Tpl2 catalytic subunit and its dissociation from ABIN2.
Handoyo H; Stafford MJ; McManus E; Baltzis D; Peggie M; Cohen P
Biochem J; 2009 Oct; 424(1):109-18. PubMed ID: 19754427
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of Tpl2 is linked to imatinib resistance and activation of MEK-ERK and NF-κB pathways in a model of chronic myeloid leukemia.
Chorzalska A; Ahsan N; Rao RSP; Roder K; Yu X; Morgan J; Tepper A; Hines S; Zhang P; Treaba DO; Zhao TC; Olszewski AJ; Reagan JL; Liang O; Gruppuso PA; Dubielecka PM
Mol Oncol; 2018 May; 12(5):630-647. PubMed ID: 29485707
[TBL] [Abstract][Full Text] [Related]
11. Identification of a novel human kinase supporter of Ras (hKSR-2) that functions as a negative regulator of Cot (Tpl2) signaling.
Channavajhala PL; Wu L; Cuozzo JW; Hall JP; Liu W; Lin LL; Zhang Y
J Biol Chem; 2003 Nov; 278(47):47089-97. PubMed ID: 12975377
[TBL] [Abstract][Full Text] [Related]
12. Sterile inflammation in acetaminophen-induced liver injury is mediated by Cot/tpl2.
Sanz-Garcia C; Ferrer-Mayorga G; González-Rodríguez Á; Valverde AM; Martín-Duce A; Velasco-Martín JP; Regadera J; Fernández M; Alemany S
J Biol Chem; 2013 May; 288(21):15342-51. PubMed ID: 23572518
[TBL] [Abstract][Full Text] [Related]
13. NF-κB1 p105 suppresses lung tumorigenesis through the Tpl2 kinase but independently of its NF-κB function.
Sun F; Qu Z; Xiao Y; Zhou J; Burns TF; Stabile LP; Siegfried JM; Xiao G
Oncogene; 2016 May; 35(18):2299-310. PubMed ID: 26300007
[TBL] [Abstract][Full Text] [Related]
14. Sensitivity of TLR4- and -7-induced NF kappa B1 p105-TPL2-ERK pathway to TNF-receptor-associated-factor-6 revealed by RNAi in mouse macrophages.
Loniewski KJ; Patial S; Parameswaran N
Mol Immunol; 2007 Jul; 44(15):3715-23. PubMed ID: 17507094
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological inhibition of TPL2/MAP3K8 blocks human cytotoxic T lymphocyte effector functions.
Chowdhury FZ; Estrada LD; Murray S; Forman J; Farrar JD
PLoS One; 2014; 9(3):e92187. PubMed ID: 24642963
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-17 induces AP-1 activity and cellular transformation via upregulation of tumor progression locus 2 activity.
Kim G; Khanal P; Lim SC; Yun HJ; Ahn SG; Ki SH; Choi HS
Carcinogenesis; 2013 Feb; 34(2):341-50. PubMed ID: 23125217
[TBL] [Abstract][Full Text] [Related]
17. Tpl2 kinase regulates T cell interferon-gamma production and host resistance to Toxoplasma gondii.
Watford WT; Hissong BD; Durant LR; Yamane H; Muul LM; Kanno Y; Tato CM; Ramos HL; Berger AE; Mielke L; Pesu M; Solomon B; Frucht DM; Paul WE; Sher A; Jankovic D; Tsichlis PN; O'Shea JJ
J Exp Med; 2008 Nov; 205(12):2803-12. PubMed ID: 19001140
[TBL] [Abstract][Full Text] [Related]
18. The role of tumor progression locus 2 protein kinase in glial inflammatory response.
Hirschhorn J; Mohanty S; Bhat NR
J Neurochem; 2014 Mar; 128(6):919-26. PubMed ID: 24188160
[TBL] [Abstract][Full Text] [Related]
19. The tyrosine kinase Syk regulates TPL2 activation signals.
Eliopoulos AG; Das S; Tsichlis PN
J Biol Chem; 2006 Jan; 281(3):1371-80. PubMed ID: 16291755
[TBL] [Abstract][Full Text] [Related]
20. Loss of Somatostatin Receptor Subtype 2 Promotes Growth of KRAS-Induced Pancreatic Tumors in Mice by Activating PI3K Signaling and Overexpression of CXCL16.
Chalabi-Dchar M; Cassant-Sourdy S; Duluc C; Fanjul M; Lulka H; Samain R; Roche C; Breibach F; Delisle MB; Poupot M; Dufresne M; Shimaoka T; Yonehara S; Mathonnet M; Pyronnet S; Bousquet C
Gastroenterology; 2015 Jun; 148(7):1452-65. PubMed ID: 25683115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
